A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study
Titel:
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study
Auteur:
Español-Rego, Marta Fernández-Martos, Carlos Elez, Elena Foguet, Carles Pedrosa, Leire Rodríguez, Nuria Ruiz-Casado, Ana Pineda, Estela Cid, Joan Cabezón, Raquel Oliveres, Helena Lozano, Miquel Ginés, Angels García-Criado, Angeles Ayuso, Juan Ramon Pagés, Mario Cuatrecasas, Miriam Torres, Ferràn Thomson, Timothy Cascante, Marta Benítez-Ribas, Daniel Maurel, Joan